
Drug Recall, Generic Bone Cancer Medication Launch Highlights Specialty Pharmacy Week in Review
A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.
A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.
Delaying Hepatitis C Treatment Increases Death Risk
Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.
Vaccine Enhances Effect of HIV Drugs
Boosting immune system improves efficacy of antiretroviral drugs.
Hepatitis C Increases Likelihood of Cancer Diagnosis
Cancer rates significantly greater compared with non-infected individuals.
Generic Levoleucovorin Launched by Sandoz
Levoleucovorin is for rescue use after high-dose methotrexate therapy in bone cancer.
Prime Time for HIV Prevention Counseling
Expanded hours may be needed to overcome treatment obstacles.
Lung Cancer Mortality May be Lowered by Long-Term Statin Use
Researchers find significant reduction in lung cancer-specific deaths.
HIV Increases Risk of Age-Related Vision Loss
Age-related macular degeneration greater in HIV-infected patients.
Teva Recalls Adrucil Injections Distributed to Pharmacies
Particulate matter found in 8 lots of Adrucil 50 mg/mL.
Diet Effects Colon Cancer Risk
Diets with more animal protein and less soluble fiber increases cancer risk.
Extended Hemophilia Treatment Safe and Effective in Children
Combination of recombinant factor VIII with a fusion protein allows for less frequent treatment.
Telomerase-Inhibition May Change Cancer Treatment
Genetically determined telomere length may not influence mortality.
Subdermal Implant Delivers Potent HIV Therapy
Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.